A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus

被引:28
作者
Manavathu, EK
Alangaden, GJ
Lerner, SA
机构
[1] Department of Internal Medicine, Wayne State University, 427 Lande Building, Detroit, MI 48201
关键词
Aspergillus fumigatus; susceptibility test; antifungals; drug resistance; broth macrodilution;
D O I
10.1139/m96-123
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of inoculum size, medium, temperature, anti duration of growth on the in vitro susceptibility testing of Aspergillus fumigatus were investigated using broth micro- and macro-dilution techniques. The minimum inhibitory concentrations (MICs) of ketoconazole, miconazole, itraconazole, fluconazole, and amphotericin B were significantly influenced by the inoculum size, regardless of the techniques used. Two- to four-fold higher MIC values were obtained when the inoculum size was increased 100-fold. The use of peptone yeast extract glucose and RPMI 1640 media provided essentially identical MIC values at 30 and 35 degrees C after incubation for 48 h or longer. A comparison of broth micro- and macro-dilution techniques revealed that, under equivalent conditions, the latter with an inoculum size between 1 x 10(3) and 1 x 10(4) conidia (strain W73355)/mL consistently provided the lowest MICs of fluconazole (256 mu g/mL), ketoconazole (8 mu g/mL), miconazole (2 mu g/mL), itraconazole (0.25 mu g/mL), and amphotericin B (0.25 mu g/mL). Using the broth macrodilution technique. we screened 24 clinical isolates of A. fumigatus obtained from the Detroit Medical Center in 1994. The MIC values of fluconazole, ketoconazole, miconazole, itraconazole and amphotericin B for all the isolates were 128-256, 8-16, 1-2, 0.25-0.5, and 0.25-1.0 mu g/mL, respectively, indicating that none of the clinical isolates that we tested shows acquired resistance to the antifungals used.
引用
收藏
页码:960 / 964
页数:5
相关论文
共 26 条
  • [1] INFECTIONS WITH ASPERGILLUS SPECIES
    ANDRIOLE, VT
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 : S481 - S486
  • [2] ASPERGILLOSIS
    BODEY, GP
    VARTIVARIAN, S
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (05) : 413 - 437
  • [3] CORRALL CJ, 1982, PEDIATRICS, V70, P455
  • [4] PULMONARY ASPERGILLOSIS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    DENNING, DW
    FOLLANSBEE, SE
    SCOLARO, M
    NORRIS, S
    EDELSTEIN, H
    STEVENS, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (10) : 654 - 662
  • [5] DENNING DW, 1990, REV INFECT DIS, V12, P1147
  • [6] SPECTROPHOTOMETRIC METHOD OF INOCULUM PREPARATION FOR THE INVITRO SUSCEPTIBILITY TESTING OF FILAMENTOUS FUNGI
    ESPINELINGROFF, A
    KERKERING, TM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) : 393 - 394
  • [7] COLLABORATIVE COMPARISON OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS
    ESPINELINGROFF, A
    KISH, CW
    KERKERING, TM
    FROMTLING, RA
    BARTIZAL, K
    GALGIANI, JN
    VILLAREAL, K
    PFALLER, MA
    GERARDEN, T
    RINALDI, MG
    FOTHERGILL, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) : 3138 - 3145
  • [8] COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI
    ESPINELINGROFF, A
    DAWSON, K
    PFALLER, M
    ANAISSIE, E
    BRESLIN, B
    DIXON, D
    FOTHERGILL, A
    PAETZNICK, V
    PETER, J
    RINALDI, M
    WALSH, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 314 - 319
  • [9] COMPARISON STUDY OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS
    ESPINELINGROFF, A
    KERKERING, TM
    GOLDSON, PR
    SHADOMY, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (06) : 1089 - 1094
  • [10] SUCCESSFUL CONTROL OF SYSTEMIC ASPERGILLUS-NIGER INFECTIONS IN 2 PATIENTS WITH ACUTE-LEUKEMIA
    GERCOVICH, FG
    RICHMAN, SP
    RODRIGUEZ, V
    LUNA, M
    MCCREDIE, KB
    BODEY, GP
    [J]. CANCER, 1975, 36 (06) : 2271 - 2276